Skip to main navigation Skip to search Skip to main content

A floating thrombus of the right ventricle in severe massive pulmonary embolism

  • Shiau Ling Huang*
  • , Chiao Hsuan Chien
  • , Yu Che Chang
  • *Corresponding author for this work
  • Chang Gung University

Research output: Contribution to journalJournal Article peer-review

7 Scopus citations

Abstract

Floating right heart thrombus (FRHT) is a severe presentation of thromboembolic disease and usually coexists with massive pulmonary embolism. Patients with FRHT are more hemodynamically compromised and usually have a higher mortality rate than patients without FRHT. An echocardiographic finding of FRHT is important because it identifies as poor prognosis. The optimal treatment in patients with FRHT remains uncertain. Heparin is more often an anticoagulant than a lytic agent. Several studies suggested that thrombolytic therapy has advantages in treating such patients. Early diagnosis and emergency therapy are important in treating patients with FRHT in the emergency department and they might have fatal outcomes when treated only with heparin.

Original languageEnglish
Pages (from-to)1071.e1-1071.e2
JournalAmerican Journal of Emergency Medicine
Volume26
Issue number9
DOIs
StatePublished - 11 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A floating thrombus of the right ventricle in severe massive pulmonary embolism'. Together they form a unique fingerprint.

Cite this